Stockpolly
Search
Delisting risk
NUWE · NASDAQ · Medical - Devices

Nuwellis (NUWE)

Hospital ultrafiltration systems and disposable treatments for fluid overload.

$0.7300
Pre-market−0.00 (−0.40%)
At close$0.7329(−3.21%)
Watchlist

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue232222222222
Cost of revenue111111111110
Gross profit111122111221
556434444465
Research & development111101111121
340330004354
General & administrative000000000004
Other expenses005003430000
Operating income−3−4−5−2−2−2−3−3−3−2−4−3
0−20−5410−10300−2
Interest expense03060−60110000
Other non-operating income0−100−400−1−300−2
Income before tax−3−6−4−82−1−3−130−2−4−5
Income tax expense000000000000
Net income from continuing operations−3−6−4−82−1−3−130−2−4−5
Net income−3−6−4−82−1−3−130−2−4−5
EPS, basic−$63.27−$1,906.80−$738.50−$660.10$2,557.80−$15.40−$24.15−$2,134.65$19.60−$52.50−$73.15−$26.64
EPS, diluted−$63.27−$1,906.80−$738.50−$660.10$2,557.80−$15.40−$24.15−$2,134.65$19.60−$52.50−$73.15−$26.64
Weighted average shares, basic0—————————00
Weighted average shares, diluted0—————————00
EBITDA−3−3−4−22−2−3−21−2−4−2
Depreciation & amortization000000000000
EBIT−3−3−4−22−2−3−20−2−4−2